These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 7831996)

  • 21. Positive correlation between reduction of handwriting area and D2 dopamine receptor occupancy during treatment with neuroleptic drugs.
    Kuenstler U; Juhnhold U; Knapp WH; Gertz HJ
    Psychiatry Res; 1999 Feb; 90(1):31-9. PubMed ID: 10320209
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of striatal dopamine D2 receptors in the occurrence of extrapyramidal side effects: iodine-123-iodobenzamide single photon emission computed tomography study.
    Corripio I; Ferreira A; Portella MJ; Pérez V; Escartí MJ; Del Valle Camacho M; Sauras RB; Alonso A; Grasa EM; Carrió I; Catafau AM; Alvarez E
    Psychiatry Res; 2012 Jan; 201(1):73-7. PubMed ID: 22281201
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dopamine D2 receptor imaging and neuroleptic drug response.
    Heinz A; Knable MB; Weinberger DR
    J Clin Psychiatry; 1996; 57 Suppl 11():84-8; discussion 89-93. PubMed ID: 8941175
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The tolerability and efficacy of the atypical neuroleptic remoxipride compared with clozapine and haloperidol in acute schizophrenia.
    Klieser E; Strauss WH; Lemmer W
    Acta Psychiatr Scand Suppl; 1994; 380():68-73. PubMed ID: 8048341
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relationship between dopamine D(2) occupancy, clinical response, and side effects: a double-blind PET study of first-episode schizophrenia.
    Kapur S; Zipursky R; Jones C; Remington G; Houle S
    Am J Psychiatry; 2000 Apr; 157(4):514-20. PubMed ID: 10739409
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Estimating dopamine D₂ receptor occupancy for doses of 8 antipsychotics: a meta-analysis.
    Lako IM; van den Heuvel ER; Knegtering H; Bruggeman R; Taxis K
    J Clin Psychopharmacol; 2013 Oct; 33(5):675-81. PubMed ID: 23948784
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment response to olanzapine and haloperidol and its association with dopamine D receptor occupancy in first-episode psychosis.
    Zipursky RB; Christensen BK; Daskalakis Z; Epstein I; Roy P; Furimsky I; Sanger T; Kapur S
    Can J Psychiatry; 2005 Jul; 50(8):462-9. PubMed ID: 16127964
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Striatal vs extrastriatal dopamine D2 receptors in antipsychotic response--a double-blind PET study in schizophrenia.
    Agid O; Mamo D; Ginovart N; Vitcu I; Wilson AA; Zipursky RB; Kapur S
    Neuropsychopharmacology; 2007 Jun; 32(6):1209-15. PubMed ID: 17077809
    [TBL] [Abstract][Full Text] [Related]  

  • 29. D2 dopamine receptor occupancy, risperidone plasma level and extrapyramidal motor symptoms in previously drug-free schizophrenic patients.
    Regenthal R; Kunstler U; Hesse S; Sabri O; Preiss R
    Int J Clin Pharmacol Ther; 2005 Aug; 43(8):370-8. PubMed ID: 16119512
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical relationship of extrapyramidal symptoms and tardive dyskinesia.
    Andrew HG
    Can J Psychiatry; 1994 Nov; 39(9 Suppl 2):S76-80. PubMed ID: 7874668
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Complete dopamine D2 receptor occupancy without extrapyramidal side effects under benperidol.
    Schönfeldt-Lecuona C; Juengling FD; Connemann BJ; Reske SN; Spitzer M; Kassubek J
    J Clin Psychopharmacol; 2004 Feb; 24(1):97-8. PubMed ID: 14709957
    [No Abstract]   [Full Text] [Related]  

  • 32. Stability of neurological signs with clozapine treatment.
    Buchanan RW; Koeppl P; Breier A
    Biol Psychiatry; 1994 Aug; 36(3):198-200. PubMed ID: 7948457
    [No Abstract]   [Full Text] [Related]  

  • 33. Extrapyramidal reactions and amine metabolites in cerebrospinal fluid during haloperidol and clozapine treatment of schizophrenic patients.
    Gerlach J; Thorsen K; Fog R
    Psychopharmacologia; 1975; 40(4):341-50. PubMed ID: 1096218
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antipsychotic drug mechanisms and neurotransmitter systems in schizophrenia.
    Reynolds GP
    Acta Psychiatr Scand Suppl; 1994; 380():36-40. PubMed ID: 7914046
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A positron emission tomography study of quetiapine in schizophrenia: a preliminary finding of an antipsychotic effect with only transiently high dopamine D2 receptor occupancy.
    Kapur S; Zipursky R; Jones C; Shammi CS; Remington G; Seeman P
    Arch Gen Psychiatry; 2000 Jun; 57(6):553-9. PubMed ID: 10839333
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical and theoretical implications of 5-HT2 and D2 receptor occupancy of clozapine, risperidone, and olanzapine in schizophrenia.
    Kapur S; Zipursky RB; Remington G
    Am J Psychiatry; 1999 Feb; 156(2):286-93. PubMed ID: 9989565
    [TBL] [Abstract][Full Text] [Related]  

  • 37. No elevated D2 dopamine receptors in neuroleptic-naive schizophrenic patients revealed by positron emission tomography and [11C]N-methylspiperone.
    Nordström AL; Farde L; Eriksson L; Halldin C
    Psychiatry Res; 1995 Aug; 61(2):67-83. PubMed ID: 7480390
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Extrapyramidal side effects of clozapine and haloperidol.
    Kurz M; Hummer M; Oberbauer H; Fleischhacker WW
    Psychopharmacology (Berl); 1995 Mar; 118(1):52-6. PubMed ID: 7597122
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High central D2-dopamine receptor occupancy as assessed with positron emission tomography in medicated but therapy-resistant schizophrenic patients.
    Coppens HJ; Slooff CJ; Paans AM; Wiegman T; Vaalburg W; Korf J
    Biol Psychiatry; 1991 Apr; 29(7):629-34. PubMed ID: 1675892
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential effects of aripiprazole on D(2), 5-HT(2), and 5-HT(1A) receptor occupancy in patients with schizophrenia: a triple tracer PET study.
    Mamo D; Graff A; Mizrahi R; Shammi CM; Romeyer F; Kapur S
    Am J Psychiatry; 2007 Sep; 164(9):1411-7. PubMed ID: 17728427
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.